Vivere Oncotherapies
Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells.
$10MSeries A
Role not disclosedTN
The National Cancer Institute
Activity from announced rounds
Activity in this selectionnomura-real-estate-development-co-f095adde
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $10M 1 disclosed · full round size, not this investor’s share